The purpose of this study is to investigate a method for diagnosing Acute Decompensated Heart Failure (ADHF) in patients who suddenly experience difficulty breathing, known as acute dyspnea. The study examines the use of a specific blood test measurement called Elecsys proBNP II and compares it to an established international strategy called the ICON cut-point strategy.
Participants in the study will have their Elecsys proBNP II levels measured. This blood test helps in understanding if the method can accurately diagnose ADHF. The study aims to validate if this method can be reliably used in emergency settings for patients with acute dyspnea.
- Who can participate: Participants must be patients aged 18 and over who experience sudden difficulty breathing and are being evaluated for heart failure.
- Study details: Participants will undergo a blood test to measure Elecsys proBNP II levels. This test is used to assess if the investigational method can diagnose heart failure.
